Updated:
Endeavour Vision
Endeavour Vision is an investment firm focused on transformative healthcare technologies. It is one of the world’s largest and most experienced investment...
Endeavour Vision
Endeavour Vision is an investment firm focused on transformative healthcare technologies. It is one of the world’s largest and most experienced investment firms focused on medical devices and digital health. Its team of entrepreneurs, scientists, and investment experts has helped shape and grow portfolio companies on both sides of the Atlantic into global leaders. The firm focuses on companies solving pressing unmet needs in health and empowers entrepreneurs to develop and commercialise technologies that modernise healthcare systems and advance patient care.
General information
Firm type
Private Equity
Year founded
2000
Location
Region
Europe
Country
Switzerland
City
Geneva
Corporate office
Rue du Rhône 1, 1204 Geneva, Switzerland
Additional offices
St Peter Port, Guernsey
Principals
Damien Tappy
President & Managing Partner
Bernard Vogel
Director
Alexander Schmitz
Partner
Stuart Manning
Partner and Director of Finance
Fernando Pacheco
Partner
Sector focus
Frequently asked questions
What investment stages does Endeavour Vision typically target?
Endeavour Vision focuses on commercially ready healthcare technology companies, spanning late-stage venture, growth, and pre-IPO rounds. Portfolio activity includes series-stage investments like the Polares Medical Series C and founding investments such as CeQur. The firm aims to support companies from initial market launch through public-market preparation.
Which sectors does Endeavour Vision explicitly avoid?
The firm's published material names only medical devices and digital health as areas of focus. Endeavour Vision does not list any standard-venture sectors such as enterprise software, fintech, or climate outside of healthcare. No portfolio companies appear outside of medical device, digital health, or healthcare services.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: